<DOC>
	<DOCNO>NCT00653393</DOCNO>
	<brief_summary>To compare single-dose Bioavailability Tranylcypromine Parnate</brief_summary>
	<brief_title>Bioavailability Study Tranylcypromine 10mg Tablets Under Fasting Conditions</brief_title>
	<detailed_description>To compare relative Bioavailability Tranylcypromine 10 mg tablet PARNATE 10mg tablet normal , healthy , men woman fast condition</detailed_description>
	<mesh_term>Tranylcypromine</mesh_term>
	<criteria>Subjects normal , healthy adult men woman volunteer participate . Is individual healthy , nonsmoking , normal adult man woman volunteer participate ? Is s/he least 18 year age ? Is his/her BMI 19 30 , exclusive ? Is willing avoid pregnancy abstain sexual intercourse , use barrier method . ( diaphragm , condom , foams/jellies , sponge ) , IUD , surgically sterile post menopausal least six month prior enter study ? Is s/he consider reliable capable understand his/her responsibility role study ? Has/s/he provide write informed consent ? A answer question indicate taht individual ineligible enrollment . Does individual history allergy hypersensitivity tranylcypromine ? Does/ s/he clinically significant laboratory abnormality would interface conduct interpretation study jeopardize his/her safety ? Does s/he significant history clinical evidence autoimmune , cardiovascular , gastrointestinal , hematopoietic , hepatic , neurological , ongoing infection , pancreatic , renal disease would interface conduct interpretation study jeopardize his/her safety ? Is nurse ? Does s/he serious psychological illness ? Does s/he significant history ( within past year ) clinical evidence alcohol drug abuse ? Does s/he positive urine drug screen saliva alcohol screen , positive HIV1 , hepatitis B C screen , positive pregnancy test ? Is s/he unable refrain use alcohol xanthinecontaining food beverage period begin 48 hour prior study drug administration end alst blood sample take ? Is s/he unable refrain ingestion smoke meat , cheese ( except cream cheese cottage cheese ) , wine beer period begin 48 hour prior study initiation end seven day last blood sample take study period two ? Has s/he use prescription drug 14day period prior study initiation , OTC drug 72hour period precede study initiation ? Is s/he unable refrain use concomitant medication study ? Ha s/he donate lose blood , participate clinical study involve drawl large volume blood ( 480mL ) , six week period precede study initiation ? Has s/he donate investigational drug 30 day period precede study initiation ? A yes answer question indicate individual ineligible enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>bioequivalence , single- dose , fast</keyword>
</DOC>